MDM2 and neoplasm: This miRNA suppressed CSC properties, possessed various anti-tumour effects against CRC cell lines and CRC cell cultures derived from clinical CRC samples through direct inhibition of KLF5 and MDM2, and provoked G1 arrest via direct inhibition of TFDP1, which forms a heterodimer with E2F1.